The identified 42 blood clinical markers included some markers previously reported to be associated with microbiome diversity such as markers for diabetes (fasting insulin, P < 10−12), inflammation (hs-CRP, P < 10−14), liver function (ALAT, P < 10−9), and cholesterol (LDL, P < 10−16). The gene discussed is INS; the disease is diabetes mellitus.